Baumhoer et al. reported that GPC3 expression was weakly identified only in 17% of medullary breast carcinomas, 20% of lobular breast carcinomas, and 15% of mucinous carcinomas [15]. This evidence concerns the gene GPC3 and medullary breast carcinoma.